# A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK012

> clinical trial · VERIFIED · 2026-07-17

Status: RECRUITING · Sponsor: Excyte Biopharma Ltd · Condition: Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

- Company: Excyte Biopharma Ltd
- Sector: Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
- Primary source: https://clinicaltrials.gov/study/NCT06565689

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.